When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial

Autores
Mammoliti, Kristie Marie; Althabe, Fernando; Easter, Christina; Devall, Adam; Martin, James; Funmi, Adeosun Love; Yusuf, Rahmatu; Abubakar, Fatima; Arigbede, Lolade Christiana; Mugambi, JimKelly; Oyoo, Polycarp; Sambusa, Masumbuko; Banda, Akwinata; Samuels, Fawzia; Willemse, Sara; Khambule, Sibongile Doris; Shu'aib, Hilal Mukhtar; Wakili, Aminu Ado; Okore, Jenipher; Mwampashi, Ard; Singata-Madliki, Mandisa; Arends, Edna; Muller, Elani; Galadanci, Hadiza; Qureshi, Zahida; Al-beity, Fadhlun Alwy; Hofmeyr, G. Justus; Fawcus, Sue; Moran, Neil; Gwako, George; Osoti, Alfred; Gallos, Ioannis; Coomarasamy, Arri
Año de publicación
2025
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Objective: To compare the frequency and timing of postpartum haemorrhage (PPH) treatment initiation between hospitals implementing the MOTIVE treatment bundle (which consisted of uterine Massage, Oxytocic drugs, Tranexamic acid, IntraVenous fluids and Examination) and those following usual care.Design: Nested prospective observational study.Setting: Hospitals in Nigeria, Kenya, Tanzania and South Africa participating in the E-MOTIVE trial.Population or sample: Healthcare workers treating PPH.Methods: Between June and December 2022, we observed healthcare workers for 1-2 weeks in 39 E-MOTIVE and 39 usual care hospitals across Nigeria, Kenya, Tanzania, and South Africa managing vaginal birth and treating PPH. We descriptively compared the frequency and timing from PPH detection to treatment initiation of individual treatments and the MOTIVE bundle, between E-MOTIVE care and usual care.Results: Among 2578 observations in E-MOTIVE care hospitals, 295 (11%) PPHs were treated, and among 2834 observations in usual care hospitals, 219 (8%) PPHs were treated. In E-MOTIVE care hospitals, 97% (286/295) of women with PPH received the MOTIVE bundle, compared to 36% (79/219) in usual care. Median initiation times for the first component were similar (0 vs. 1 min), but E-MOTIVE care hospitals achieved faster initiation of all components (13 min, IQR 6-18) compared to usual care (18 min, IQR 10-25). In total, 79% (233/295) of women in E-MOTIVE care had all components initiated within 20 min, compared to 22% (48/219) in usual care.Conclusions: Timely and comprehensive management of PPH using the MOTIVE bundle, particularly initiating all components within 15-20 min, was commonly observed in the E-MOTIVE care hospitals. Scaling up E-MOTIVE care should emphasise timely bundle initiation to strengthen PPH treatment and improve maternal health outcomes in low-and-middle-income countries.
Fil: Mammoliti, Kristie Marie. University Of Birmingham;
Fil: Althabe, Fernando. Organizacion Mundial de la Salud; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Easter, Christina. University Of Birmingham;
Fil: Devall, Adam. University Of Birmingham;
Fil: Martin, James. University Of Birmingham;
Fil: Funmi, Adeosun Love. Bayero University; Nigeria
Fil: Yusuf, Rahmatu. Bayero University; Nigeria
Fil: Abubakar, Fatima. Bayero University; Nigeria
Fil: Arigbede, Lolade Christiana. Bayero University; Nigeria
Fil: Mugambi, JimKelly. University Of Nairobi; Kenia
Fil: Oyoo, Polycarp. University Of Nairobi; Kenia
Fil: Sambusa, Masumbuko. Muhimbili University Of Health And Allied Sciences; Tanzania
Fil: Banda, Akwinata. Muhimbili University Of Health And Allied Sciences; Tanzania
Fil: Samuels, Fawzia. University of Cape Town; Sudáfrica
Fil: Willemse, Sara. University of Cape Town; Sudáfrica
Fil: Khambule, Sibongile Doris. University of Cape Town; Sudáfrica. University of the Witwatersrand; Sudáfrica
Fil: Shu'aib, Hilal Mukhtar. Bayero University; Nigeria
Fil: Wakili, Aminu Ado. Bayero University; Nigeria
Fil: Okore, Jenipher. University Of Nairobi; Kenia
Fil: Mwampashi, Ard. Muhimbili University Of Health And Allied Sciences; Tanzania
Fil: Singata-Madliki, Mandisa. University of Cape Town; Sudáfrica. University of the Witwatersrand; Sudáfrica
Fil: Arends, Edna. University of Cape Town; Sudáfrica
Fil: Muller, Elani. University of the Witwatersrand; Sudáfrica
Fil: Galadanci, Hadiza. Bayero University; Nigeria
Fil: Qureshi, Zahida. University Of Nairobi; Kenia
Fil: Al-beity, Fadhlun Alwy. Muhimbili University Of Health And Allied Sciences; Tanzania
Fil: Hofmeyr, G. Justus. University of the Witwatersrand; Sudáfrica
Fil: Fawcus, Sue. University of Cape Town; Sudáfrica
Fil: Moran, Neil. University Of Kwazulu-natal; Sudáfrica. Kwazulu-natal Department Of Health; Sudáfrica
Fil: Gwako, George. University Of Nairobi; Kenia
Fil: Osoti, Alfred. University Of Nairobi; Kenia
Fil: Gallos, Ioannis. Organizacion Mundial de la Salud; Argentina
Fil: Coomarasamy, Arri. University Of Birmingham;
Materia
MOTIVE bundle
postpartum haemorrhage
PPH
PPH TREATMENT
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/291118
Acceder
id CONICETDig_3364a78f8ddda50e7fa0d21a37f766f6
oai_identifier_str oai:ri.conicet.gov.ar:11336/291118
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE TrialMammoliti, Kristie MarieAlthabe, FernandoEaster, ChristinaDevall, AdamMartin, JamesFunmi, Adeosun LoveYusuf, RahmatuAbubakar, FatimaArigbede, Lolade ChristianaMugambi, JimKellyOyoo, PolycarpSambusa, MasumbukoBanda, AkwinataSamuels, FawziaWillemse, SaraKhambule, Sibongile DorisShu'aib, Hilal MukhtarWakili, Aminu AdoOkore, JenipherMwampashi, ArdSingata-Madliki, MandisaArends, EdnaMuller, ElaniGaladanci, HadizaQureshi, ZahidaAl-beity, Fadhlun AlwyHofmeyr, G. JustusFawcus, SueMoran, NeilGwako, GeorgeOsoti, AlfredGallos, IoannisCoomarasamy, ArriMOTIVE bundlepostpartum haemorrhagePPHPPH TREATMENThttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Objective: To compare the frequency and timing of postpartum haemorrhage (PPH) treatment initiation between hospitals implementing the MOTIVE treatment bundle (which consisted of uterine Massage, Oxytocic drugs, Tranexamic acid, IntraVenous fluids and Examination) and those following usual care.Design: Nested prospective observational study.Setting: Hospitals in Nigeria, Kenya, Tanzania and South Africa participating in the E-MOTIVE trial.Population or sample: Healthcare workers treating PPH.Methods: Between June and December 2022, we observed healthcare workers for 1-2 weeks in 39 E-MOTIVE and 39 usual care hospitals across Nigeria, Kenya, Tanzania, and South Africa managing vaginal birth and treating PPH. We descriptively compared the frequency and timing from PPH detection to treatment initiation of individual treatments and the MOTIVE bundle, between E-MOTIVE care and usual care.Results: Among 2578 observations in E-MOTIVE care hospitals, 295 (11%) PPHs were treated, and among 2834 observations in usual care hospitals, 219 (8%) PPHs were treated. In E-MOTIVE care hospitals, 97% (286/295) of women with PPH received the MOTIVE bundle, compared to 36% (79/219) in usual care. Median initiation times for the first component were similar (0 vs. 1 min), but E-MOTIVE care hospitals achieved faster initiation of all components (13 min, IQR 6-18) compared to usual care (18 min, IQR 10-25). In total, 79% (233/295) of women in E-MOTIVE care had all components initiated within 20 min, compared to 22% (48/219) in usual care.Conclusions: Timely and comprehensive management of PPH using the MOTIVE bundle, particularly initiating all components within 15-20 min, was commonly observed in the E-MOTIVE care hospitals. Scaling up E-MOTIVE care should emphasise timely bundle initiation to strengthen PPH treatment and improve maternal health outcomes in low-and-middle-income countries.Fil: Mammoliti, Kristie Marie. University Of Birmingham;Fil: Althabe, Fernando. Organizacion Mundial de la Salud; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; ArgentinaFil: Easter, Christina. University Of Birmingham;Fil: Devall, Adam. University Of Birmingham;Fil: Martin, James. University Of Birmingham;Fil: Funmi, Adeosun Love. Bayero University; NigeriaFil: Yusuf, Rahmatu. Bayero University; NigeriaFil: Abubakar, Fatima. Bayero University; NigeriaFil: Arigbede, Lolade Christiana. Bayero University; NigeriaFil: Mugambi, JimKelly. University Of Nairobi; KeniaFil: Oyoo, Polycarp. University Of Nairobi; KeniaFil: Sambusa, Masumbuko. Muhimbili University Of Health And Allied Sciences; TanzaniaFil: Banda, Akwinata. Muhimbili University Of Health And Allied Sciences; TanzaniaFil: Samuels, Fawzia. University of Cape Town; SudáfricaFil: Willemse, Sara. University of Cape Town; SudáfricaFil: Khambule, Sibongile Doris. University of Cape Town; Sudáfrica. University of the Witwatersrand; SudáfricaFil: Shu'aib, Hilal Mukhtar. Bayero University; NigeriaFil: Wakili, Aminu Ado. Bayero University; NigeriaFil: Okore, Jenipher. University Of Nairobi; KeniaFil: Mwampashi, Ard. Muhimbili University Of Health And Allied Sciences; TanzaniaFil: Singata-Madliki, Mandisa. University of Cape Town; Sudáfrica. University of the Witwatersrand; SudáfricaFil: Arends, Edna. University of Cape Town; SudáfricaFil: Muller, Elani. University of the Witwatersrand; SudáfricaFil: Galadanci, Hadiza. Bayero University; NigeriaFil: Qureshi, Zahida. University Of Nairobi; KeniaFil: Al-beity, Fadhlun Alwy. Muhimbili University Of Health And Allied Sciences; TanzaniaFil: Hofmeyr, G. Justus. University of the Witwatersrand; SudáfricaFil: Fawcus, Sue. University of Cape Town; SudáfricaFil: Moran, Neil. University Of Kwazulu-natal; Sudáfrica. Kwazulu-natal Department Of Health; SudáfricaFil: Gwako, George. University Of Nairobi; KeniaFil: Osoti, Alfred. University Of Nairobi; KeniaFil: Gallos, Ioannis. Organizacion Mundial de la Salud; ArgentinaFil: Coomarasamy, Arri. University Of Birmingham;Wiley Blackwell Publishing, Inc2025-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/291118Mammoliti, Kristie Marie; Althabe, Fernando; Easter, Christina; Devall, Adam; Martin, James; et al.; When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial; Wiley Blackwell Publishing, Inc; BJOG - An International Journal of Obstetrics and Gynaecology; 132; 11; 8-2025; 1664-16721470-0328CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.18293info:eu-repo/semantics/altIdentifier/doi/10.1111/1471-0528.18293info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-08-25T15:28:22Zoai:ri.conicet.gov.ar:11336/291118instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-08-25 15:28:22.555CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial
title When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial
spellingShingle When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial
Mammoliti, Kristie Marie
MOTIVE bundle
postpartum haemorrhage
PPH
PPH TREATMENT
title_short When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial
title_full When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial
title_fullStr When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial
title_full_unstemmed When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial
title_sort When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial
dc.creator.none.fl_str_mv Mammoliti, Kristie Marie
Althabe, Fernando
Easter, Christina
Devall, Adam
Martin, James
Funmi, Adeosun Love
Yusuf, Rahmatu
Abubakar, Fatima
Arigbede, Lolade Christiana
Mugambi, JimKelly
Oyoo, Polycarp
Sambusa, Masumbuko
Banda, Akwinata
Samuels, Fawzia
Willemse, Sara
Khambule, Sibongile Doris
Shu'aib, Hilal Mukhtar
Wakili, Aminu Ado
Okore, Jenipher
Mwampashi, Ard
Singata-Madliki, Mandisa
Arends, Edna
Muller, Elani
Galadanci, Hadiza
Qureshi, Zahida
Al-beity, Fadhlun Alwy
Hofmeyr, G. Justus
Fawcus, Sue
Moran, Neil
Gwako, George
Osoti, Alfred
Gallos, Ioannis
Coomarasamy, Arri
author Mammoliti, Kristie Marie
author_facet Mammoliti, Kristie Marie
Althabe, Fernando
Easter, Christina
Devall, Adam
Martin, James
Funmi, Adeosun Love
Yusuf, Rahmatu
Abubakar, Fatima
Arigbede, Lolade Christiana
Mugambi, JimKelly
Oyoo, Polycarp
Sambusa, Masumbuko
Banda, Akwinata
Samuels, Fawzia
Willemse, Sara
Khambule, Sibongile Doris
Shu'aib, Hilal Mukhtar
Wakili, Aminu Ado
Okore, Jenipher
Mwampashi, Ard
Singata-Madliki, Mandisa
Arends, Edna
Muller, Elani
Galadanci, Hadiza
Qureshi, Zahida
Al-beity, Fadhlun Alwy
Hofmeyr, G. Justus
Fawcus, Sue
Moran, Neil
Gwako, George
Osoti, Alfred
Gallos, Ioannis
Coomarasamy, Arri
author_role author
author2 Althabe, Fernando
Easter, Christina
Devall, Adam
Martin, James
Funmi, Adeosun Love
Yusuf, Rahmatu
Abubakar, Fatima
Arigbede, Lolade Christiana
Mugambi, JimKelly
Oyoo, Polycarp
Sambusa, Masumbuko
Banda, Akwinata
Samuels, Fawzia
Willemse, Sara
Khambule, Sibongile Doris
Shu'aib, Hilal Mukhtar
Wakili, Aminu Ado
Okore, Jenipher
Mwampashi, Ard
Singata-Madliki, Mandisa
Arends, Edna
Muller, Elani
Galadanci, Hadiza
Qureshi, Zahida
Al-beity, Fadhlun Alwy
Hofmeyr, G. Justus
Fawcus, Sue
Moran, Neil
Gwako, George
Osoti, Alfred
Gallos, Ioannis
Coomarasamy, Arri
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv MOTIVE bundle
postpartum haemorrhage
PPH
PPH TREATMENT
topic MOTIVE bundle
postpartum haemorrhage
PPH
PPH TREATMENT
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Objective: To compare the frequency and timing of postpartum haemorrhage (PPH) treatment initiation between hospitals implementing the MOTIVE treatment bundle (which consisted of uterine Massage, Oxytocic drugs, Tranexamic acid, IntraVenous fluids and Examination) and those following usual care.Design: Nested prospective observational study.Setting: Hospitals in Nigeria, Kenya, Tanzania and South Africa participating in the E-MOTIVE trial.Population or sample: Healthcare workers treating PPH.Methods: Between June and December 2022, we observed healthcare workers for 1-2 weeks in 39 E-MOTIVE and 39 usual care hospitals across Nigeria, Kenya, Tanzania, and South Africa managing vaginal birth and treating PPH. We descriptively compared the frequency and timing from PPH detection to treatment initiation of individual treatments and the MOTIVE bundle, between E-MOTIVE care and usual care.Results: Among 2578 observations in E-MOTIVE care hospitals, 295 (11%) PPHs were treated, and among 2834 observations in usual care hospitals, 219 (8%) PPHs were treated. In E-MOTIVE care hospitals, 97% (286/295) of women with PPH received the MOTIVE bundle, compared to 36% (79/219) in usual care. Median initiation times for the first component were similar (0 vs. 1 min), but E-MOTIVE care hospitals achieved faster initiation of all components (13 min, IQR 6-18) compared to usual care (18 min, IQR 10-25). In total, 79% (233/295) of women in E-MOTIVE care had all components initiated within 20 min, compared to 22% (48/219) in usual care.Conclusions: Timely and comprehensive management of PPH using the MOTIVE bundle, particularly initiating all components within 15-20 min, was commonly observed in the E-MOTIVE care hospitals. Scaling up E-MOTIVE care should emphasise timely bundle initiation to strengthen PPH treatment and improve maternal health outcomes in low-and-middle-income countries.
Fil: Mammoliti, Kristie Marie. University Of Birmingham;
Fil: Althabe, Fernando. Organizacion Mundial de la Salud; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Easter, Christina. University Of Birmingham;
Fil: Devall, Adam. University Of Birmingham;
Fil: Martin, James. University Of Birmingham;
Fil: Funmi, Adeosun Love. Bayero University; Nigeria
Fil: Yusuf, Rahmatu. Bayero University; Nigeria
Fil: Abubakar, Fatima. Bayero University; Nigeria
Fil: Arigbede, Lolade Christiana. Bayero University; Nigeria
Fil: Mugambi, JimKelly. University Of Nairobi; Kenia
Fil: Oyoo, Polycarp. University Of Nairobi; Kenia
Fil: Sambusa, Masumbuko. Muhimbili University Of Health And Allied Sciences; Tanzania
Fil: Banda, Akwinata. Muhimbili University Of Health And Allied Sciences; Tanzania
Fil: Samuels, Fawzia. University of Cape Town; Sudáfrica
Fil: Willemse, Sara. University of Cape Town; Sudáfrica
Fil: Khambule, Sibongile Doris. University of Cape Town; Sudáfrica. University of the Witwatersrand; Sudáfrica
Fil: Shu'aib, Hilal Mukhtar. Bayero University; Nigeria
Fil: Wakili, Aminu Ado. Bayero University; Nigeria
Fil: Okore, Jenipher. University Of Nairobi; Kenia
Fil: Mwampashi, Ard. Muhimbili University Of Health And Allied Sciences; Tanzania
Fil: Singata-Madliki, Mandisa. University of Cape Town; Sudáfrica. University of the Witwatersrand; Sudáfrica
Fil: Arends, Edna. University of Cape Town; Sudáfrica
Fil: Muller, Elani. University of the Witwatersrand; Sudáfrica
Fil: Galadanci, Hadiza. Bayero University; Nigeria
Fil: Qureshi, Zahida. University Of Nairobi; Kenia
Fil: Al-beity, Fadhlun Alwy. Muhimbili University Of Health And Allied Sciences; Tanzania
Fil: Hofmeyr, G. Justus. University of the Witwatersrand; Sudáfrica
Fil: Fawcus, Sue. University of Cape Town; Sudáfrica
Fil: Moran, Neil. University Of Kwazulu-natal; Sudáfrica. Kwazulu-natal Department Of Health; Sudáfrica
Fil: Gwako, George. University Of Nairobi; Kenia
Fil: Osoti, Alfred. University Of Nairobi; Kenia
Fil: Gallos, Ioannis. Organizacion Mundial de la Salud; Argentina
Fil: Coomarasamy, Arri. University Of Birmingham;
description Objective: To compare the frequency and timing of postpartum haemorrhage (PPH) treatment initiation between hospitals implementing the MOTIVE treatment bundle (which consisted of uterine Massage, Oxytocic drugs, Tranexamic acid, IntraVenous fluids and Examination) and those following usual care.Design: Nested prospective observational study.Setting: Hospitals in Nigeria, Kenya, Tanzania and South Africa participating in the E-MOTIVE trial.Population or sample: Healthcare workers treating PPH.Methods: Between June and December 2022, we observed healthcare workers for 1-2 weeks in 39 E-MOTIVE and 39 usual care hospitals across Nigeria, Kenya, Tanzania, and South Africa managing vaginal birth and treating PPH. We descriptively compared the frequency and timing from PPH detection to treatment initiation of individual treatments and the MOTIVE bundle, between E-MOTIVE care and usual care.Results: Among 2578 observations in E-MOTIVE care hospitals, 295 (11%) PPHs were treated, and among 2834 observations in usual care hospitals, 219 (8%) PPHs were treated. In E-MOTIVE care hospitals, 97% (286/295) of women with PPH received the MOTIVE bundle, compared to 36% (79/219) in usual care. Median initiation times for the first component were similar (0 vs. 1 min), but E-MOTIVE care hospitals achieved faster initiation of all components (13 min, IQR 6-18) compared to usual care (18 min, IQR 10-25). In total, 79% (233/295) of women in E-MOTIVE care had all components initiated within 20 min, compared to 22% (48/219) in usual care.Conclusions: Timely and comprehensive management of PPH using the MOTIVE bundle, particularly initiating all components within 15-20 min, was commonly observed in the E-MOTIVE care hospitals. Scaling up E-MOTIVE care should emphasise timely bundle initiation to strengthen PPH treatment and improve maternal health outcomes in low-and-middle-income countries.
publishDate 2025
dc.date.none.fl_str_mv 2025-08
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/291118
Mammoliti, Kristie Marie; Althabe, Fernando; Easter, Christina; Devall, Adam; Martin, James; et al.; When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial; Wiley Blackwell Publishing, Inc; BJOG - An International Journal of Obstetrics and Gynaecology; 132; 11; 8-2025; 1664-1672
1470-0328
CONICET Digital
CONICET
url http://hdl.handle.net/11336/291118
identifier_str_mv Mammoliti, Kristie Marie; Althabe, Fernando; Easter, Christina; Devall, Adam; Martin, James; et al.; When Is Postpartum Haemorrhage Treatment Initiated? A Nested Observational Study Within the E‐MOTIVE Trial; Wiley Blackwell Publishing, Inc; BJOG - An International Journal of Obstetrics and Gynaecology; 132; 11; 8-2025; 1664-1672
1470-0328
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.18293
info:eu-repo/semantics/altIdentifier/doi/10.1111/1471-0528.18293
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1874775362382069760
score 13.24418

Publicaciones similares